EGFR and neoplasm: As measured by histological analysis, ABY-029 performed expectedly better in the visualization of EGFR-expressing tumors (91% accuracy, 80% overall accuracy), while 5-ALA performed better in the visualization of the tumor margins of non-EGFR-expressing tumors (87% accuracy, 84% overall accuracy).